Search Results for: lung cancer

deCODE genetics has announced the launch of the first focused genetic scans for assessing personal risk of several major cardiovascular diseases and common cancers.

DxS Ltd has expanded its license with Genzyme Genetics, a business unit of Genzyme Corporation, for epidermal growth factor receptor (EGFR) to include the United States and Canada.

Rosetta Genomics, Ltd. announced the introduction of its third diagnostic test, miRview(TM) meso.

Rosetta Genomics, Ltd has announced the commercial availability of its second diagnostic test, miRview mets. The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia.